Company Overview of Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. develops and commercializes therapeutics for autoimmune diseases, inflammation, and pain in the United States and Europe. It develops Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, including pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. Cerimon Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Francisco, California.
701 Gateway Boulevard
South San Francisco
San Francisco, CA 94080
Founded in 2004
Key Executives for Cerimon Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Scholar Rock, Inc.||United States|
|Pamlab, L.L.C.||United States|
|T3D Therapeutics, Inc.||United States|
|Therapeutics, Inc.||United States|
|Centocor Ortho Biotech Services LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Cerimon Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.